Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Cash Flows (Unaudited)

Condensed Statement of Cash Flows (Unaudited)
9 Months Ended
Jun. 30, 2018
USD ($)
Operating Activities  
Net loss $ (19,949)
Adjustments to reconcile net loss to net cash used in operating activities:  
Interest earned on marketable securities held in Trust Account (1,144,095)
Change in operating assets and liabilities:  
Receivable from related party (8,570)
Prepaid expenses (182,318)
Accounts payable 105,837
Other current liabilities 195,156
Net cash used in operating activities (1,053,939)
Investing Activities  
Investment of cash in Trust Account, net (143,750,000)
Cash withdrawn from Trust Account 183,677
Net cash used in investing activities (143,566,323)
Financing Activities  
Proceeds from sale of Units, net of underwriting discounts paid 141,162,440
Proceeds from sale of Private Placement Units 4,982,560
Proceeds from the sale of Founder Shares 25,000
Promissory notes from related parties 50,536
Repayment of promissory notes from related parties (50,536)
Payment of deferred offering costs (664,499)
Net cash provided by financing activities 145,505,501
Net change in cash and cash equivalents 885,239
Cash and cash equivalents, end of period 885,239
Supplemental disclosure of noncash investing activities  
Change in value of common stock subject to possible redemption $ 104,000